Doctor of Podiatric Medicine Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Anthony Borgia

Podiatrist, Foot & Ankle Surgery Las Vegas, NV Doctor of Podiatric Medicine

NPI 1104850635 CMS profile 94811

9260 W Sunset Rd Ste 201, Las Vegas, NV 89148

Open in the dashboard

General payments

$46,700

127 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Anthony Borgia of Las Vegas, NV is reported in the CMS Open Payments database as having received $46,700 across 127 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $63 3
2023 General $1,321 26
2022 General $24,201 26
2021 General $20,417 35
2020 General $201 10
2019 General $497 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony Borgia
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Anthony Borgia were reported at $0. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Anthony Borgia Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $497 $389 $118–$1,406 $163
2020 $201 $191 $62–$691 $114
2021 $20,417 $329 $104–$1,341 $132
2022 $24,201 $419 $125–$1,611 $149
2023 $1,321 $377 $128–$1,164 $160
2024 $63 $394 $134–$1,168 $164
2025 $0 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. AngioDynamics, Inc. $40,836 12 payments
  2. Orthofix Medical, Inc. $1,809 10 payments
  3. Goode Surgical Inc $1,227 3 payments
  4. Smith+Nephew, Inc. $466 20 payments
  5. Curonix LLC $417 5 payments
  6. AbbVie, Inc. $356 22 payments
  7. Stryker Corporation $260 4 payments
  8. Treace Medical Concepts, Inc. $210 4 payments
  9. Melinta Therapeutics, Inc. $175 7 payments
  10. Misonix Inc $155 3 payments
  11. Other $789 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Long term medical supply or device loan $23,700 4 payments
  2. Education $18,336 9 payments
  3. Food and Beverage $3,131 108 payments
  4. Travel and Lodging $1,533 6 payments
Products named General payments · program years 2019–2024
  1. Auryon Laser System 100-120 Vac $37,958 6 payments
  2. VenaCure 1470 Pro $2,400 2 payments
  3. TL-HEX TRUELOK HEXAPOD SYSTEM $1,801 9 payments
  4. DALVANCE $488 32 payments
  5. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $417 5 payments
  6. C3 WAVE SYSTEM $417 2 payments
  7. LAPIPLASTY SYSTEM $210 4 payments
  8. HOFFMANN $150 1 payment
  9. STRAVIX PL $144 1 payment
  10. Orbactiv $144 6 payments
  11. Other $1,517 79 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$530

Medicare's payments for the services billed

Medicare patients

15

Average age 71

Services billed

16

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 73%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DALVANCE
  • AbbVie, Inc. $20
$20 — —
TEFLARO
  • AbbVie, Inc. $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record